金陵药业(000919) - 2015 Q1 - 季度财报(更新)

Important Notes This section provides the company's management statement regarding the accuracy and completeness of the quarterly report. Board of Directors' Statement The Board of Directors, Supervisory Committee, and senior management ensure the truthfulness, accuracy, and completeness of this quarterly report, assuming legal responsibility. - Company management guarantees the truthfulness, accuracy, and completeness of this quarterly report, free from false records, misleading statements, or material omissions[4] - Company head Shen Zhilong, chief accountant Li Chunmin, and head of accounting department Wang Yang affirm the truthfulness, accuracy, and completeness of the financial statements in this quarterly report[5] Key Financial Data and Shareholder Changes This section presents the company's key financial performance indicators and details of shareholder structure for the reporting period. Key Accounting Data and Financial Indicators In Q1 2015, revenue grew by 12.10% and net profit attributable to shareholders increased by 40.06%, though non-recurring items significantly influenced profit growth. Key Financial Indicators | Indicator | Current Period (RMB) | Prior Period (RMB) | Year-over-Year Change | | :--- | :--- | :--- | :--- | | Operating Revenue | 712,972,532.63 | 636,029,342.61 | 12.10% | | Net Profit Attributable to Shareholders | 57,242,147.84 | 40,869,293.48 | 40.06% | | Net Profit Excluding Non-Recurring Items | 38,959,109.47 | 40,908,478.44 | -4.77% | | Net Cash Flow from Operating Activities | -27,872,984.43 | -10,968,313.37 | -154.12% | | Basic Earnings Per Share (RMB/share) | 0.1136 | 0.0811 | 40.07% | | Total Assets | 3,597,515,418.98 | 3,622,217,110.96 | -0.68% (Compared to Beginning of Year) | | Net Assets Attributable to Shareholders | 2,377,953,915.16 | 2,320,642,964.82 | 2.47% (Compared to Beginning of Year) | Non-Recurring Gains and Losses | Non-Recurring Item | Amount (RMB) | | :--- | :--- | | Gains/Losses from Disposal of Non-Current Assets | 11,134,196.29 | | Gains/Losses from Financial Assets Held for Trading | 12,116,753.49 | | Government Grants | 77,738.00 | | Other Non-Operating Income/Expenses | -1,239,833.62 | | Total | 18,283,038.37 | Shareholder Information As of the reporting period end, the company had 26,534 common shareholders, with Nanjing Xingong Investment Group Co., Ltd. as the largest shareholder. - Total common shareholders at the end of the reporting period were 26,534[12] Top Ten Shareholders | Shareholder Name | Shareholder Nature | Shareholding Percentage | Number of Shares Held | | :--- | :--- | :--- | :--- | | Nanjing Xingong Investment Group Co., Ltd. | State-owned Legal Person | 45.23% | 227,943,839 | | Fuzhou Investment Management Co. | State-owned Legal Person | 4.94% | 24,920,000 | | Hefei Industrial Investment Holding Co., Ltd. | State | 3.29% | 16,581,871 | | Sinochem Lantian Group Co., Ltd. | State | 3.09% | 15,588,765 | | National Social Security Fund 404 Portfolio | Domestic Non-State-owned Legal Person | 1.19% | 5,999,846 | Significant Events This section details significant changes in financial items, ongoing commitments, and investment activities during the reporting period. Analysis of Changes in Major Financial Items Several financial indicators showed significant changes due to the consolidation of a subsidiary, gains from equity transfer, fair value changes, and financing activities. - Management expenses increased by 32.14% year-over-year, primarily due to the consolidation of Nanjing Gulou Hospital Group Anqing Petrochemical Hospital[17] - Investment income increased by 86.01% year-over-year, mainly due to increased gains from the transfer of 100% equity in Hefei Limin Pharmaceutical Co., Ltd[17] - Fair value change gains increased by 245.25% year-over-year, primarily due to a significant increase in the fair value of financial assets held for trading at period-end[17] - Net cash flow from operating activities decreased by 154.12% year-over-year due to increased cash payments to employees; net cash flow from investing activities increased by 110.45% year-over-year due to increased cash recovery from investments; net cash flow from financing activities decreased by 97.49% year-over-year due to reduced borrowings[17][18] Commitments The controlling shareholder's commitment to resolve horizontal competition, made in August 2014, continues to be fulfilled as planned. - The controlling shareholder, Nanjing Xingong Investment Group Co., Ltd., is fulfilling its commitment to resolve horizontal competition, with a five-year commitment period[19] Operating Performance Forecast The company has not provided a forecast or warning for its operating performance for January-June 2015. - The company has not issued a forecast or warning regarding its cumulative net profit for the first half of 2015[21] Securities Investment At period-end, the company held approximately 170.25 million RMB in financial assets held for trading, generating about 6.91 million RMB in current period gains. Securities Investment Portfolio | Investment Category | Period-end Book Value (RMB) | Current Period Gains/Losses (RMB) | | :--- | :--- | :--- | | Stocks, Bonds, Funds, etc. | 170,251,977.03 | 6,908,885.20 | Holdings in Other Listed Companies The company holds 362,500 shares of Nanjing Bank Co., Ltd., classified as available-for-sale financial assets, with a period-end book value of 5.38 million RMB. - The company holds shares in Nanjing Bank, with a period-end book value of 5,383,125 RMB, classified as available-for-sale financial assets[23] Financial Statements This section presents the company's consolidated financial statements, including the balance sheet, income statement, and cash flow statement. Consolidated Balance Sheet As of March 31, 2015, total assets were 3.60 billion RMB, total liabilities were 781.07 million RMB, and owners' equity attributable to the parent company was 2.38 billion RMB. Consolidated Balance Sheet Summary | Item | Period-end Balance (RMB) | Beginning of Period Balance (RMB) | | :--- | :--- | :--- | | Total Assets | 3,597,515,418.98 | 3,622,217,110.96 | | Total Liabilities | 781,069,688.63 | 871,239,863.72 | | Total Owners' Equity Attributable to Parent Company | 2,377,953,915.16 | 2,320,642,964.82 | Consolidated Income Statement In Q1 2015, total operating revenue reached 712.97 million RMB, with net profit attributable to the parent company at 57.24 million RMB, driven by fair value and investment gains. Consolidated Income Statement Summary | Item | Current Period Amount (RMB) | Prior Period Amount (RMB) | | :--- | :--- | :--- | | Total Operating Revenue | 712,972,532.63 | 636,029,342.61 | | Operating Profit | 91,355,043.78 | 61,581,991.69 | | Net Profit Attributable to Parent Company | 57,242,147.84 | 40,869,293.48 | | Basic Earnings Per Share | 0.1136 | 0.0811 | Consolidated Cash Flow Statement Q1 2015 saw negative net cash flow from operating activities, positive from investing activities, and negative from financing activities, reflecting changes in operations, investments, and debt. Consolidated Cash Flow Statement Summary | Item | Current Period Amount (RMB) | Prior Period Amount (RMB) | | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | -27,872,984.43 | -10,968,313.37 | | Net Cash Flow from Investing Activities | 7,318,539.52 | -70,322,356.64 | | Net Cash Flow from Financing Activities | -26,112,857.14 | -13,222,634.28 | | Net Increase in Cash and Cash Equivalents | -46,781,369.77 | -94,646,209.53 | Audit Report The company's first-quarter report for 2015 has not been audited. - The company's first-quarter report is unaudited[52]